These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 2195239)

  • 1. The BN acute myelocytic leukemia (BNML) (a rat model for studying human acute myelocytic leukemia (AML)).
    Martens AC; Van Bekkum DW; Hagenbeek A
    Leukemia; 1990 Apr; 4(4):241-57. PubMed ID: 2195239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Minimal residual disease in leukemia: studies in an animal model for acute myelocytic leukemia (BNML).
    Martens AC; van Bekkum DW; Hagenbeek A
    Int J Cell Cloning; 1990 Jan; 8(1):27-38. PubMed ID: 2403582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative studies on graft-versus-leukemia after allogeneic bone marrow transplantation in rat models for acute myelocytic and lymphocytic leukemia.
    Kloosterman TC; Tielemans MJ; Martens AC; van Bekkum DW; Hagenbeek A
    Bone Marrow Transplant; 1994 Jul; 14(1):15-22. PubMed ID: 7951103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Graft-versus-leukemia in rat MHC-mismatched bone marrow transplantation is merely an allogeneic effect.
    Kloosterman TC; Martens AC; van Bekkum DW; Hagenbeek A
    Bone Marrow Transplant; 1995 Apr; 15(4):583-90. PubMed ID: 7655385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A second prophylactic MHC-mismatched bone marrow transplantation protects against rat acute myeloid leukemia (BNML) without lethal graft-versus-host disease.
    Nestvold JM; Omdal BK; Dai KZ; Martens A; Benestad HB; Vaage JT; Rolstad B
    Transplantation; 2008 Jan; 85(1):102-11. PubMed ID: 18192919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cryopreservation of autologous marrow grafts in acute leukemia: survival of in vivo clonogenic leukemic cells and normal hemopoietic stem cells.
    Hagenbeek A; Martens AC
    Leukemia; 1989 Jul; 3(7):535-7. PubMed ID: 2659904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Minimum residual leukemic cells in genetically marked brown Norway rat myelocytic leukemia model].
    Yan Y; Martens AC; Van Bekkum DW
    Zhonghua Zhong Liu Za Zhi; 1992 Nov; 14(6):414-7. PubMed ID: 1304472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of acetyldinaline for treatment of minimal residual disease (MRD): preclinical studies in the BNML rat model for human acute myelocytic leukemia.
    el-Beltagi HM; Martens AC; Dahab GM; Hagenbeek A
    Leukemia; 1993 Nov; 7(11):1795-800. PubMed ID: 8231248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of acute myelocytic leukemia with interleukin-6 Pseudomonas exotoxin fusion protein in a rat leukemia model.
    Rozemuller H; Rombouts WJ; Touw IP; FitzGerald DJ; Kreitman RJ; Pastan I; Hagenbeek A; Martens AC
    Leukemia; 1996 Nov; 10(11):1796-803. PubMed ID: 8892684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of minimal disease in acute leukemia using flow cytometry: studies in a rat model for human acute leukemia.
    Martens AC; Hagenbeek A
    Cytometry; 1985 Jul; 6(4):342-7. PubMed ID: 3860369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bivariate flow karyotyping of acute myelocytic leukemia in the BNML rat model.
    Arkesteijn GJ; Martens AC; Jonker RR; Hagemeijer A; Hagenbeek A
    Cytometry; 1987 Nov; 8(6):618-24. PubMed ID: 3480794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of high-dose cyclophosphamide in combination with total-body irradiation in the treatment of acute myelocytic leukemia: studies in a relevant rat model.
    Hagenbeek A; Martens AC
    Cancer Res; 1983 Jan; 43(1):408-12. PubMed ID: 6336603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-2 therapy after allogeneic bone marrow transplantation for acute myelocytic leukemia: studies in a relevant rat model for AML.
    Kloosterman TC; Martens AC; Osterwalder B; Hagenbeek A
    Bone Marrow Transplant; 1994 Dec; 14(6):965-73. PubMed ID: 7711675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retrovirus-mediated transfer and expression of marker genes in the BN rat acute myelocytic leukemia model for the study of minimal residual disease (MRD).
    Yan Y; Martens AC; de Groot CJ; Hendrikx PJ; Valerio D; van Bekkum DW; Hagenbeek A
    Leukemia; 1993 Jan; 7(1):131-9. PubMed ID: 8418372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro resistance of the brown Norway rat acute myelocytic leukemia (BNML) to lymphokine-activated killer activity.
    Gaiser JF; Kloosterman TC; Martens AC; Hagenbeek A
    Leukemia; 1993 May; 7(5):736-41. PubMed ID: 8483327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of ultraviolet-B irradiation on engraftment, graft-versus-host disease and graft-versus-leukemia effect in a rat model for allogeneic bone marrow transplantation.
    Gowing H; Braakman E; Hagenbeek A; Lawler M; McCann SR; Pamphilon DH; Martens AC
    Bone Marrow Transplant; 1998 Apr; 21(8):801-7. PubMed ID: 9603404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo development of an acetyldinaline resistant subline of the BN rat acute myelocytic leukemia (BNML).
    el-Beltagi HM; Martens AC; Haroun EA; Hagenbeek A
    Leukemia; 1993 Aug; 7(8):1275-80. PubMed ID: 8350629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Minimal residual disease in leukemia: state of the art 1991.
    Hagenbeek A
    Leukemia; 1992; 6 Suppl 2():12-6. PubMed ID: 1578911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dinaline: a new oral drug against leukemia? Preclinical studies in a relevant rat model for human acute myelocytic leukemia (BNML).
    Hagenbeek A; Weiershausen U; Martens AC
    Leukemia; 1988 Apr; 2(4):226-30. PubMed ID: 3163079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The contribution of residual leukemic cells in the graft to leukemia relapse after autologous bone marrow transplantation: mathematical considerations.
    Schultz FW; Martens AC; Hagenbeek A
    Leukemia; 1989 Jul; 3(7):530-4. PubMed ID: 2659903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.